# Biot Korea

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biot-korea

- Industry: Medical Devices & Equipment
- Headquarters: Gwangju, South Korea
- Website: www.biotinc.com
- Total disclosed funding: $3.4M
- Latest round: Series A (Aug 17, 2021)
- Investors on record: 4

## About

Based in Gwangju, South Korea, and founded in 2017,  Biot Korea Inc. is a stem cell navigator that delivers therapeutic agents to the affected part of the patient's body. Biot Korea Inc. has received original technology from Korea Micro Medical Robot Research Institute and Korea Institute of Machinery and Materials, which are public research institutes in the medical robot field. The company has partnered with public research institutes, including Korea University Anam Hospital for its first clinical trial and license for the non-face-to-face specimen collection robot. The company developed Stem Cell Navigator, a medical robot platform that requires a core magnetic field generator that delivers functional material to the patient, and a wearable device that is worn to hold micro scaffolds in order for the treatment to reach the target area. Biot Korea Inc. plans to start clinical trials using its medical robot platform and expand production facilities.

## Funding rounds

- Series A, Aug 17, 2021, $3.4M — Korea Investment Partners, Daesung Private Equity, Enlight Ventures
- Seed, Nov 26, 2018 — Korea Tech Incubator for Startup, Enlight Ventures

## Investors

- Korea Tech Incubator for Startup — Seed
- Enlight Ventures (https://capitalatlas.ai/funds/enlight-ventures) — Seed, Series A
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- Daesung Private Equity (https://capitalatlas.ai/funds/daesung-private-equity) — Series A